RETRACTED: Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene.
- DOI
- 10.1097/jto.0b013e3181753b24
- Published
- 2008 Jun
- Container
- Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/jto.0b013e3181753b24,
title = {RETRACTED: Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene.},
author = {Li T and Ling YH and Perez-Soler R},
year = {2008},
journal = {Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer},
doi = {10.1097/jto.0b013e3181753b24},
url = {https://doi.org/10.1097/jto.0b013e3181753b24}
}RIS
TY - JOUR TI - RETRACTED: Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene. AU - Li T AU - Ling YH AU - Perez-Soler R PY - 2008 JO - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer DO - 10.1097/jto.0b013e3181753b24 UR - https://doi.org/10.1097/jto.0b013e3181753b24 ER -
APA
T, L., YH, L., & R, P. (2008). RETRACTED: Tumor dependence on the EGFR signaling pathway expressed by the p-EGFR:p-AKT ratio predicts erlotinib sensitivity in human non-small cell lung cancer (NSCLC) cells expressing wild-type EGFR gene.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. https://doi.org/10.1097/jto.0b013e3181753b24
Source records
- pubmed · retrieved 2026-09-25T23:07:08.524Z
- europe-pmc · retrieved 2026-09-25T23:07:08.802Z